The prevalence of type 2 diabetes is rising globally, with a disproportionate impact on individuals in low-income and middle-income countries, where access to care and new therapies is often limited.

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The risi ...